Delivery Order 36F79719D0246-36C77026N0048
Award Date 9/8/26
Potential Completion Date 9/22/26
Potential Value $237K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raleigh, NC 27615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Merz Pharmaceuticals, LLC was awarded a delivery order valued at $709,836.48 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, for the supply of Levodopa pharmaceutical products. The contract, awarded on March 9, 2026, with a completion date of March 20, 2026, operates under a firm fixed-price structure with no set-aside designation. Performance will take place in Raleigh, North Carolina. This delivery order is issued under...
- This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Merz Pharmaceuticals, LLC, a foreign-owned for-profit organization. The contract is for the supply of LEVODOPA NDC 10144-0342-60, a pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a ceiling value of $653,990.40 and a period of performance through October 9, 2024. This contract...
- Veterans Integrated Service Network 5 issued a $22,508.03 delivery order to Merck Sharp & Dohme LLC on May 7, 2026, for pharmacy services under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The parent FSS-61-IB contract, awarded June 1, 2025, and extending through May 31, 2030, provides pharmaceutical and drug procurement across Veterans Integrated Service Networks. Place of performance is Carrollton, TX. The delivery order is priced...
- <p>Veterans Integrated Service Network 20 issued a $374,438.72 delivery order to Exelan Pharmaceuticals Inc. on October 1, 2025, for Lenalidomide pharmaceutical supply, with ultimate completion on March 31, 2026.</p> <p>The order is issued under the Pharmaceuticals and Drugs GSA Federal Supply Schedule (FSS-61-IB). Place of performance is Cary, NC. The order carries firm fixed pricing and no set-aside designation.</p>
- Veterans Integrated Service Network 20 issued a $481,321.66 delivery order to Exelan Pharmaceuticals Inc. on January 19, 2026, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for lenalidomide oncology treatment in multiple milligrams for veterans. Place of performance is Cary, NC 27513. The order carries a firm fixed price and an ultimate completion date of January 18, 2027. No set-aside was used. The Pharmaceuticals and Drugs FSS is a multi-billion-dollar GSA...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 20, issued a $42,781.70 delivery order to Merck Sharp & Dohme LLC on May 4, 2026, for pharmaceutical supply to the Puget Sound VA Medical Center. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), a $5.84 billion GSA Schedule contract awarded to Merck on June 1, 2025, and extending through May 31, 2030. Place of performance is Bartlett, TN 38134. The order has...
- Veterans Integrated Service Network 5 issued a delivery order to UCB Pharma, Inc. on March 4, 2026, for Zilbrysq 32.4 mg with a ceiling value of $31,040.96, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Pittsburgh, PA. The order carries an ultimate completion date of March 17, 2026. This is a firm fixed-price delivery order with no set-aside designation. The Federal Supply Schedule establishes pre-negotiated pricing for pharmaceutical products...
- <p>Veterans Integrated Service Network 20 issued a $918,830.88 delivery order to Exelan Pharmaceuticals Inc. on June 1, 2026, for Lenalidomide 5 mg capsules, oral, with an ultimate completion date of May 31, 2027.</p> <p>The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Cary, NC 27513. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
- Veterans Integrated Service Network 5 issued a $47,052.30 delivery order to Actelion Pharmaceuticals US, Inc. on April 3, 2026, under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) for OPSUMIT 10 MG pharmaceutical supply. The FSS-61-IB is a multiple-award schedule contract for pharmaceuticals and drugs valued at $219.1 million with a period of performance from August 1, 2024, through July 31, 2029. Place of performance is Lake Mary, FL. The order is priced on a firm...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Janssen Biotech, Inc. to provide BALVERSA 4MG. The place of performance is Carrollton, Texas. The period of performance is September 13-14, 2023. This delivery order supports the VA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79719D0246Federal Supply Schedule
- 36F79719D0246-36C77026N0048Delivery Order
Veterans Integrated Service Network 12 issued a $236,612.16 delivery order to Merz Pharmaceuticals, LLC on September 8, 2026, for Levodopa supply under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Raleigh, NC. The order carries a firm fixed price and ultimate completion date of September 22, 2026. No set-aside applies to this delivery order.
Generated 9/5/26, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $236.6k | 9/2/26 |